CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-06-08 | Lewis Mary Beth Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 60,000 | ||
| 2012-06-08 | Bateman Terry Allan Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 60,000 | ||
| 2012-05-18 | Khuchua Vladimir EVP and Chief Content Officer | Purchase | +3,500 | $0.20 | $700 | 18,500 |
| 2012-03-26 | Duckett Peter A. SVP of Sales | Grant or award · STOCK OPTION (RIGHT TO BUY) | +50,000 | 150,000 | ||
| 2012-02-28 | Berg Jeffrey Alan Director | Purchase | +8,000,000 | $0.25 | $2.0M | 16,024,643 |
| 2012-02-24 | BUSH MICHAEL J CEO | Option exercise | +119,907 | $0.25 | $30K | 420,385 |
| 2012-02-24 | BUSH MICHAEL J CEO | Option exercise · Subscription Rights (right to buy) | −119,907 | 0 | ||
| 2012-02-24 | Berg Jeffrey Alan Director | Other acquisition | +1,669,043 | $0.25 | $417K | 8,024,643 |
| 2012-02-24 | Berg Jeffrey Alan Director | Other disposition · Subscription Rights (right to buy) | −1,669,043 | 0 | ||
| 2011-09-20 | Khuchua Vladimir EVP and Chief Content Officer | Purchase | +5,000 | $0.37 | $2K | 15,000 |
| 2011-09-13 | Khuchua Vladimir EVP and Chief Content Officer | Purchase | +10,000 | $0.43 | $4K | 10,000 |
| 2011-06-17 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 50,000 | ||
| 2011-06-17 | Lewis Mary Beth Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 40,000 | ||
| 2011-06-17 | Bateman Terry Allan Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 40,000 | ||
| 2011-04-18 | BUSH MICHAEL J CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 2,280,000 | ||
| 2011-03-21 | Duckett Peter A. SVP of Sales | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2011-02-07 | Khuchua Vladimir EVP and Chief Content Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2010-12-17 | Berg Jeffrey Alan Director | Purchase | +500,000 | $0.34 | $170K | 6,355,600 |
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +146,900 | $0.34 | $50K | 297,378 |
| 2010-12-17 | BUSH MICHAEL J CEO | Purchase | +100 | $0.34 | $34 | 297,478 |
Page 25 of 33 · 657 trades